Literature DB >> 33673715

Diverse Adiposity and Atrio-Ventricular Dysfunction across Obesity Phenotypes: Implication of Epicardial Fat Analysis.

Yau-Huei Lai1,2,3, Lawrence Yu-Min Liu1,2,3, Kuo-Tzu Sung1,3,4, Jui-Peng Tsai1,3,4, Wen-Hung Huang1,3,4, Chun-Ho Yun1,3,4,5, Jiun-Lu Lin1,6, Ying-Ju Chen7, Cheng-Huang Su1,3,4, Ta-Chuan Hung1,3,4, Chung-Lieh Hung1,3,4,7, Jen-Yuan Kuo1,3,4.   

Abstract

Obesity has been conceptualized as a highly heterogeneous condition. We aim to investigate chamber-specific effects of obesity on the heart and relevant outcomes. A total of 2944 symptom-free individuals (age: 47.5 ± 10.0 years), free of known cardiovascular diseases were classified into four categories based on body mass index (BMI) (as normal-weight (NW) vs. overweight/obese (O)) and metabolic status (metabolically-healthy (MH) vs. unhealthy (MU)). Epicardial adipose thickness (EAT) using echocardiography method. Speckle-tracking based atrio-ventricular (LA/LV) deformations including global longitudinal strain (GLS) and peak atrial longitudinal strain (PALS) were also analyzed. MUNW had higher cardiometabolic risks and more impaired diastolic and GLS/PALS than MHNW phenotype. Both MHO and MUO phenotypes exhibited worst atrial functions. Greater EAT was independently associated with worse GLS and PALS after correcting for various anthropometrics, LV mass and LA volume, respectively, with unfavorable LA effects from EAT being more pronounced in the NW phenotypes (both p interactions < 0.05). During a median follow-up period of 5.3 years, BMI/EAT improved the reclassification for atrial fibrillation (AF) incidence (p for net reclassification improvement < 0.05) mainly in the NW phenotypes (p interaction < 0.001). Categorization of clinical obesity phenotypes based on excessive visceral adiposity likely provides increment prognostic impacts on atrial dysfunction, particularly in non-obese phenotypes.

Entities:  

Keywords:  atrial fibrillation; atrio-ventricular deformations; epicardial adiposity thickness; metabolically unhealthy normal-weight; obesity

Year:  2021        PMID: 33673715      PMCID: PMC7997462          DOI: 10.3390/diagnostics11030408

Source DB:  PubMed          Journal:  Diagnostics (Basel)        ISSN: 2075-4418


  38 in total

Review 1.  Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies.

Authors: 
Journal:  Lancet       Date:  2004-01-10       Impact factor: 79.321

2.  Epicardial adipose tissue relating to anthropometrics, metabolic derangements and fatty liver disease independently contributes to serum high-sensitivity C-reactive protein beyond body fat composition: a study validated with computed tomography.

Authors:  Yau-Huei Lai; Chun-Ho Yun; Fei-Shih Yang; Chuan-Chuan Liu; Yih-Jer Wu; Jen-Yuan Kuo; Hung-I Yeh; Tin-Yu Lin; Hiram G Bezerra; Shou-Chuan Shih; Cheng-Ho Tsai; Chung-Lieh Hung
Journal:  J Am Soc Echocardiogr       Date:  2011-10-20       Impact factor: 5.251

3.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.

Authors:  Roberto M Lang; Luigi P Badano; Victor Mor-Avi; Jonathan Afilalo; Anderson Armstrong; Laura Ernande; Frank A Flachskampf; Elyse Foster; Steven A Goldstein; Tatiana Kuznetsova; Patrizio Lancellotti; Denisa Muraru; Michael H Picard; Ernst R Rietzschel; Lawrence Rudski; Kirk T Spencer; Wendy Tsang; Jens-Uwe Voigt
Journal:  J Am Soc Echocardiogr       Date:  2015-01       Impact factor: 5.251

4.  New method for evaluating left ventricular wall motion by color-coded tissue Doppler imaging: in vitro and in vivo studies.

Authors:  K Miyatake; M Yamagishi; N Tanaka; M Uematsu; N Yamazaki; Y Mine; A Sano; M Hirama
Journal:  J Am Coll Cardiol       Date:  1995-03-01       Impact factor: 24.094

5.  Visceral adiposity and the risk of metabolic syndrome across body mass index: the MESA Study.

Authors:  Ravi V Shah; Venkatesh L Murthy; Siddique A Abbasi; Ron Blankstein; Raymond Y Kwong; Allison B Goldfine; Michael Jerosch-Herold; João A C Lima; Jingzhong Ding; Matthew A Allison
Journal:  JACC Cardiovasc Imaging       Date:  2014-11-05

Review 6.  Epicardial fat and atrial fibrillation: current evidence, potential mechanisms, clinical implications, and future directions.

Authors:  Christopher X Wong; Anand N Ganesan; Joseph B Selvanayagam
Journal:  Eur Heart J       Date:  2017-05-01       Impact factor: 29.983

Review 7.  Pathophysiology of human visceral obesity: an update.

Authors:  André Tchernof; Jean-Pierre Després
Journal:  Physiol Rev       Date:  2013-01       Impact factor: 37.312

8.  Left Atrial Epicardial Fat Volume Is Associated With Atrial Fibrillation: A Prospective Cardiovascular Magnetic Resonance 3D Dixon Study.

Authors:  Shiro Nakamori; Maryam Nezafat; Long H Ngo; Warren J Manning; Reza Nezafat
Journal:  J Am Heart Assoc       Date:  2018-03-23       Impact factor: 5.501

9.  Multimorbidity in patients with heart failure from 11 Asian regions: A prospective cohort study using the ASIAN-HF registry.

Authors:  Jasper Tromp; Wan Ting Tay; Wouter Ouwerkerk; Tiew-Hwa Katherine Teng; Jonathan Yap; Michael R MacDonald; Kirsten Leineweber; John J V McMurray; Michael R Zile; Inder S Anand; A Mark Richards; Carolyn S P Lam
Journal:  PLoS Med       Date:  2018-03-27       Impact factor: 11.069

10.  Epicardial fat in heart failure patients with mid-range and preserved ejection fraction.

Authors:  Gijs van Woerden; Thomas M Gorter; B Daan Westenbrink; Tineke P Willems; Dirk J van Veldhuisen; Michiel Rienstra
Journal:  Eur J Heart Fail       Date:  2018-08-01       Impact factor: 15.534

View more
  1 in total

1.  Association of Non-Alcoholic Fatty Liver Disease and Hepatic Fibrosis with Epicardial Adipose Tissue Volume and Atrial Deformation Mechanics in a Large Asian Population Free from Clinical Heart Failure.

Authors:  Yau-Huei Lai; Cheng-Huang Su; Ta-Chuan Hung; Chun-Ho Yun; Cheng-Ting Tsai; Hung-I Yeh; Chung-Lieh Hung
Journal:  Diagnostics (Basel)       Date:  2022-04-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.